RESPIRA THERAPEUTICS INC has a total of 39 patent applications. It decreased the IP activity by 62.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets medical technology and pharmaceuticals are PETTIS RONALD J, WISE ALLY HOLDINGS LTD and GLAXO WELLCOME LAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 9 | |
#3 | EPO (European Patent Office) | 8 | |
#4 | Canada | 4 | |
#5 | China | 3 | |
#6 | India | 2 | |
#7 | Mexico | 2 | |
#8 | Australia | 1 | |
#9 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Syringes | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Smyth Hugh | 22 |
#2 | Xu Zhen | 19 |
#3 | Hannon James | 16 |
#4 | Deaton Dan | 16 |
#5 | Donovan Martin J | 14 |
#6 | Donovan Martin | 14 |
#7 | Curtis Robert | 12 |
#8 | Curtis Robert M | 11 |
#9 | Gibbons Aileen | 9 |
#10 | Shreeniwas Revati | 9 |
Publication | Filing date | Title |
---|---|---|
WO2020251983A1 | Carrier-based formulations and related methods | |
EP3612259A1 | Powder dispersion devices and methods | |
EP3554507A1 | Methods and compositions for treatment of pulmonary hypertension and other lung disorders | |
CA2972826A1 | Powder dispersion methods and devices | |
EP3110484A2 | Powder inhaler, system and methods | |
US2015314086A1 | Powder inhaler, system and methods | |
WO2015089105A1 | Pde5 inhibitor powder formulations and methods relating thereto | |
US2013213397A1 | Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents | |
EP2648788A1 | Dry powder inhaler |